The Scalability Challenge in MSC Therapies
June 12, 2026
John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success
4 min read
False
Advertisement
Cell & Gene
Roving Reporter Asks: What Emerging Approaches Could Define the Next Wave of Advanced Therapies?
June 11, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy
Building the Cell Therapy Ecosystem
June 8, 2026
Antoinette Gawin discusses leadership, innovation in blood and cell therapy, and the global systems shaping access to advanced medicine
10 min read
This Week’s CGT News: Promising Data for In Vivo CAR T
June 8, 2026
Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts
5 min read
Roving Reporter Asks: How Is Shifting Investment Reshaping Advanced Therapies?
June 4, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how a tougher funding environment is sharpening focus on scalability, cost-efficiency, partnerships, and commercialization in advanced therapies
1 min read
This Week’s CGT News: Base Editing Takes Aim at Cholesterol
June 1, 2026
Verve reports phase 1 data for one-time PCSK9 base editing; plus: neuroprotective gene therapy, non-viral DNA delivery, tumour-activated CAR-T, and in vivo CAR-M
3 min read
Roving Reporter Asks: Where Is Real Progress Being Made in Manufacturing and Supply Chain?
May 28, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how automation, AI, closed systems, and smarter supply chain models are helping advanced therapies move toward scalable delivery
When Insight Meets Urgency in Cell and Gene Therapy
By Ruizhi Wang, Alan J. Dickson
May 27, 2026
Balancing deep biological insight with the realities of development is now central to progress in advanced medicine
6 min read
Infrastructure at Scale: A Conversation with Germfree’s New CEO
May 26, 2026
We speak with Carol Houts about advanced therapy manufacturing, modular cleanrooms, and the challenge of scaling GMP infrastructure
7 min read
Cell Therapy Manufacturing: A Medicine Maker’s “Dream”
May 25, 2026
Why CTMC CEO Jason Bock relishes the challenge of solving cell therapy’s most complex manufacturing and delivery problems
13 min read
